BioVoice News March 2017 Issue 10 Volume 1 | Page 46

tech talk

Since I joined last year , I haven ’ t come across any major concern on funding or the lack of it . The purchases continue to happen in both private and government segments . So , I think the funding crunch has eased a bit . Also , initially the government would fund any project it wanted to but now it is asking questions on the utility .
They are asking how much is the translational research , the number of research papers , and the benefit to society . Some institutes were used to unquestioned funding but now they have to answer the question , which of course is a good move on the part of government . They have the responsibility to produce something that will help in making life simpler , healthier and better . The taxpayers ’ money now must have accountability .
Q : What are the set of clients you cater to ?
Our customers are researchers and scientists both in institutes and private sector . Apart from that clinicians and pathological labs such as Dr Lal PathLabs ,
46 BioVoiceNews | March 2017